http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022001194-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8fb0df0b05738afc3f0e0aafced7341
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0644
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
filingDate 2019-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492e8bc2dec6b162f5d891a43554d2b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0ad8eab704bba68575fad8834e8f6af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_628295d1c7c7606ec2f4e0aec8a15758
publicationDate 2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022001194-A1
titleOfInvention Photobiomodulation therapy to improve functional mobility of stroke survivors
abstract Photobiomodulation therapy (PBMT) can be used to improve functional mobility of stroke survivors. A light source device can be contacted to a subject's skin proximal to an area of hemiplegia within a subject due to the stroke. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the area of hemiplegia. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the area of hemiplegia to improve the functional mobility of the subject.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426600-B2
priorityDate 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282219

Total number of triples: 29.